ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Prognostic significance of tumor regression grade in esophageal squamous cell carcinoma after neoadjuvant chemoradiation

Zhang, Chi; Xu, Fei; Qiang, Yong; Cong, Zhuang-Zhuang; Wang, Qin; Zhang, Zheng; Luo, Chao; Qiu, Bing-Mei*; Hu, Li-Wen*; Shen, Yi*南方医科大学; 南京大学; y
Frontiers in Surgery2023-1-6DOI: 10.3389/fsurg.2022.1029575
1被引15阅读
引用收藏
分享

摘要

BackgroundsTrimodal therapy (neoadjuvant chemoradiotherapy followed by esophagectomy) for locally advanced esophageal squamous cell carcinoma (ESCC) is associated with a significant survival benefit. Modified Ryan score is an effective tool to evaluated the tumor regression grade (TRG) after neoadjuvant therapy. The aim of this study was to evaluate the prognostic value of TRG for overall survival (OS) and disease-free survival (DFS) in ESCC patients undergoing neoadjuvant chemoradiation. MethodsThe study retrospectively reviewed 523 ESCC patients who underwent neoadjuvant chemoradiotherapy and radical esophagectomy at Jinling Hospital from January 2014 to July 2020. Kaplan-Meier curves with log-rank test and Cox regression model were used to evaluate the prognostic factor of TRG based on modified Ryan scoring system on OS and DFS. ResultsAfter application of inclusion and exclusion criteria, 494 patients with ESCC following neoadjuvant chemoradiotherapy and radical esophagectomy were available for analysis. The TRG scores are significantly associated with smoke history (p = 0.02), lymphovascular invasion (LVI) and/or peripheral nerve invasion (PNI) (p < 0.01), and postoperative adjuvant therapy (p < 0.01). Meanwhile, tumor characteristics including tumor length (p < 0.01) and tumor differentiation grade (p < 0.01) are also significantly associated with TRG score. The results of multivariable Cox regression modal showed that TRG is not an independently prognostic factor for OS (p = 0.922) or DFS (p = 0.526) but tumor length is an independently prognostic factor for DFS (p = 0.046). ConclusionsThis study evaluated the prognostic value of modified Ryan scoring system for ESCC after trimodal therapy and concluded that modified Ryan scoring system can predict survival and recurrence rates but is not an independently prognostic factor for OS and DFS.

学科与关键词

关键词
esophageal squamous cell carcinomaneoadjuvant chemoradiotherapyesophagectomytumor regression grademodified ryan scoring system
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Surgery
发表日期
2023-01-06
卷期
第 9 卷
页码
1029575
DOI
10.3389/fsurg.2022.1029575
成果收录
SCIE

作者

  • Z

    Zhang, Chi (第一作者)

    nanjing univ

  • X

    Xu, Fei

    nanjing med univ

查看全部 10 位作者收起作者
  • Q

    Qiang, Yong

    southeast univ

  • C

    Cong, Zhuang-Zhuang

    nanjing univ

  • W

    Wang, Qin

    nanjing univ

  • Z

    Zhang, Zheng

    nanjing med univ

  • L

    Luo, Chao

    southern med univ

  • Q

    Qiu, Bing-Mei (通讯)

  • H

    Hu, Li-Wen (通讯)

    nanjing univ

  • S

    Shen, Yi (通讯)

    nanjing med univ · southern med univ · southeast univ · nanjing univ

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417